Longevity Health Holdings, Inc.
XAGE
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -84.96% | -98.65% | -99.12% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -84.96% | -98.65% | -99.12% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 49.12% | 48.87% | 7.34% | -1.41% | -6.90% |
| Depreciation & Amortization | -13.15% | -14.20% | -8.94% | -3.99% | 1.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.82% | -3.23% | -43.21% | -21.29% | -8.73% |
| Operating Income | 3.71% | 4.19% | 43.63% | 21.48% | 8.73% |
| Income Before Tax | 51.47% | 33.68% | 49.54% | 2.42% | -90.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.02% | 34.28% | 49.54% | 2.42% | -90.30% |
| Earnings from Discontinued Operations | -100.00% | -62.88% | 243.32% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.06% | 32.87% | 71.01% | 8.81% | -79.24% |
| EBIT | 3.71% | 4.19% | 43.63% | 21.48% | 8.73% |
| EBITDA | 3.54% | 4.01% | 44.08% | 21.75% | 8.90% |
| EPS Basic | 93.04% | 93.46% | 96.67% | 94.87% | 45.15% |
| Normalized Basic EPS | 92.60% | 92.67% | 94.57% | 94.28% | 37.83% |
| EPS Diluted | 93.04% | 93.46% | 96.67% | 94.87% | 45.15% |
| Normalized Diluted EPS | 92.60% | 92.67% | 94.57% | 94.28% | 37.83% |
| Average Basic Shares Outstanding | 39.52% | 92.69% | 283.56% | 1,538.05% | 67.56% |
| Average Diluted Shares Outstanding | 39.52% | 92.69% | 283.56% | 1,538.05% | 67.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |